Annual Long Term Debt
$6.01 M
-$1.13 M-15.82%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual long term debt is $6.01 million, with the most recent change of -$1.13 million (-15.82%) on April 30, 2024.
- During the last 3 years, KALV annual long term debt has risen by +$969.00 thousand (+19.20%).
- KALV annual long term debt is now -16.59% below its all-time high of $7.21 million, reached on April 1, 2022.
Performance
KALV Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$4.67 M
-$313.00 K-6.28%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly long term debt is $4.67 million, with the most recent change of -$313.00 thousand (-6.28%) on October 31, 2024.
- Over the past year, KALV quarterly long term debt has dropped by -$1.34 million (-22.28%).
- KALV quarterly long term debt is now -41.66% below its all-time high of $8.01 million, reached on July 31, 2022.
Performance
KALV Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
KALV Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.8% | -22.3% |
| 3 y3 years | +19.2% | -24.9% |
| 5 y5 years | +100.0% | +344.0% |
KALV Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.6% | +19.2% | -41.7% | at low |
| 5 y | 5-year | -16.6% | -100.0% | -41.7% | +404.9% |
| alltime | all time | -16.6% | -100.0% | -41.7% | -100.0% |
KalVista Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $4.67 M(-6.3%) |
| Jul 2024 | - | $4.99 M(-17.1%) |
| Apr 2024 | $6.01 M(-15.8%) | $6.01 M(-3.9%) |
| Jan 2024 | - | $6.26 M(-4.4%) |
| Oct 2023 | - | $6.55 M(-4.6%) |
| Jul 2023 | - | $6.87 M(-3.9%) |
| Apr 2023 | $7.14 M(-0.9%) | $7.14 M(-3.7%) |
| Jan 2023 | - | $7.42 M(-3.7%) |
| Oct 2022 | - | $7.71 M(-3.9%) |
| Jul 2022 | - | $8.01 M(+11.1%) |
| Apr 2022 | - | $7.21 M(-3.4%) |
| Apr 2022 | $7.21 M(+42.9%) | - |
| Jan 2022 | - | $7.47 M(+20.0%) |
| Oct 2021 | - | $6.22 M(-3.9%) |
| Jul 2021 | - | $6.47 M(+28.3%) |
| Apr 2021 | $5.05 M(+377.4%) | $5.05 M(+349.3%) |
| Jan 2021 | - | $1.12 M(+20.5%) |
| Oct 2020 | - | $932.00 K(-7.7%) |
| Jul 2020 | - | $1.01 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2020 | $1.06 M(>+9900.0%) | $1.06 M(+14.1%) |
| Jan 2020 | - | $926.00 K(-12.1%) |
| Oct 2019 | - | $1.05 M(-10.5%) |
| Jul 2019 | - | $1.18 M(>+9900.0%) |
| Apr 2019 | $0.00(-100.0%) | $0.00(0.0%) |
| Jan 2019 | - | $0.00(0.0%) |
| Oct 2018 | - | $0.00(0.0%) |
| Jul 2018 | - | $0.00(-100.0%) |
| Apr 2018 | $58.00 K(-98.2%) | $58.00 K(-50.4%) |
| Jan 2018 | - | $117.00 K(-21.5%) |
| Oct 2017 | - | $149.00 K(-30.0%) |
| Jul 2017 | - | $213.00 K(-92.1%) |
| Mar 2016 | - | $2.70 M(-14.4%) |
| Dec 2015 | $3.15 M(+48.0%) | $3.15 M(-12.4%) |
| Sep 2015 | - | $3.60 M(-10.8%) |
| Jun 2015 | - | $4.04 M(+18.6%) |
| Mar 2015 | - | $3.40 M(+59.7%) |
| Dec 2014 | $2.13 M | $2.13 M(+28.5%) |
| Sep 2014 | - | $1.66 M |
FAQ
- What is KalVista Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual long term debt year-on-year change?
- What is KalVista Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly long term debt year-on-year change?
What is KalVista Pharmaceuticals annual long term debt?
The current annual long term debt of KALV is $6.01 M
What is the all time high annual long term debt for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual long term debt is $7.21 M
What is KalVista Pharmaceuticals annual long term debt year-on-year change?
Over the past year, KALV annual long term debt has changed by -$1.13 M (-15.82%)
What is KalVista Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of KALV is $4.67 M
What is the all time high quarterly long term debt for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly long term debt is $8.01 M
What is KalVista Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, KALV quarterly long term debt has changed by -$1.34 M (-22.28%)